91 related articles for article (PubMed ID: 24365408)
1. Transcriptional complexity of the HSPG2 gene in the human mast cell line, HMC-1.
Lord MS; Jung M; Cheng B; Whitelock JM
Matrix Biol; 2014 Apr; 35():123-31. PubMed ID: 24365408
[TBL] [Abstract][Full Text] [Related]
2. Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing.
Jung M; Lord MS; Cheng B; Lyons JG; Alkhouri H; Hughes JM; McCarthy SJ; Iozzo RV; Whitelock JM
J Biol Chem; 2013 Feb; 288(5):3289-304. PubMed ID: 23235151
[TBL] [Abstract][Full Text] [Related]
3. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome.
Stum M; Davoine CS; Vicart S; Guillot-Noël L; Topaloglu H; Carod-Artal FJ; Kayserili H; Hentati F; Merlini L; Urtizberea JA; Hammouda el-H; Quan PC; Fontaine B; Nicole S
Hum Mutat; 2006 Nov; 27(11):1082-91. PubMed ID: 16927315
[TBL] [Abstract][Full Text] [Related]
5. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the perlecan/HSPG2 gene and its activation in regenerating Nematostella vectensis.
Warren CR; Kassir E; Spurlin J; Martinez J; Putnam NH; Farach-Carson MC
PLoS One; 2015; 10(4):e0124578. PubMed ID: 25876075
[TBL] [Abstract][Full Text] [Related]
7. Perlecan is essential for cartilage and cephalic development.
Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y
Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953
[TBL] [Abstract][Full Text] [Related]
8. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization, expression profiles of the porcine SDC2 and HSPG2 genes and their association with hematologic parameters.
Wang W; Tao C; Zhou P; Zhou X; Zhang Q; Liu B
Mol Biol Rep; 2013 Mar; 40(3):2549-56. PubMed ID: 23264070
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate of perlecan is involved in glomerular filtration.
Morita H; Yoshimura A; Inui K; Ideura T; Watanabe H; Wang L; Soininen R; Tryggvason K
J Am Soc Nephrol; 2005 Jun; 16(6):1703-10. PubMed ID: 15872080
[TBL] [Abstract][Full Text] [Related]
11. Perlecan-deficient mutation impairs corneal epithelial structure.
Inomata T; Ebihara N; Funaki T; Matsuda A; Watanabe Y; Ning L; Xu Z; Murakami A; Arikawa-Hirasawa E
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1277-84. PubMed ID: 22266517
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Domain V of Human Perlecan Is a Bioactive Vascular Proteoglycan.
Rnjak-Kovacina J; Tang F; Lin X; Whitelock JM; Lord MS
Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 28846206
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment.
Warren CR; Grindel BJ; Francis L; Carson DD; Farach-Carson MC
J Cell Biochem; 2014 Jul; 115(7):1322-33. PubMed ID: 24700612
[TBL] [Abstract][Full Text] [Related]
14. Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the
Shu CC; Smith SM; Little CB; Melrose J
Biochem J; 2019 Jan; 476(2):225-243. PubMed ID: 30563944
[TBL] [Abstract][Full Text] [Related]
15. Expression of murine beta 7, alpha 4, and beta 1 integrin genes by rodent mast cells.
Gurish MF; Bell AF; Smith TJ; Ducharme LA; Wang RK; Weis JH
J Immunol; 1992 Sep; 149(6):1964-72. PubMed ID: 1381390
[TBL] [Abstract][Full Text] [Related]
16. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen.
Vuoriluoto K; Jokinen J; Kallio K; Salmivirta M; Heino J; Ivaska J
Exp Cell Res; 2008 Nov; 314(18):3369-81. PubMed ID: 18657535
[TBL] [Abstract][Full Text] [Related]
18. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
Arikawa-Hirasawa E; Wilcox WR; Le AH; Silverman N; Govindraj P; Hassell JR; Yamada Y
Nat Genet; 2001 Apr; 27(4):431-4. PubMed ID: 11279527
[TBL] [Abstract][Full Text] [Related]
19. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
20. Perlecan--a multifunctional extracellular proteoglycan scaffold.
Farach-Carson MC; Carson DD
Glycobiology; 2007 Sep; 17(9):897-905. PubMed ID: 17442708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]